Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA
Update: 2025-08-13
Description
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Ulrich Neumann, MBA, MSc, MA, Director of Access and Policy Research at Johnson & Johnson, to discuss the motivation behind the recent launch of the J&J Center for U.S. Healthcare Policy Research, the interconnectedness and importance of the various players within the biopharmaceutical R&D ecosystem, and the private capital that is required to develop new drugs.
Resources mentioned in this episode:
https://policyresearch.jnj.com
https://jnjinnovation.com/home
https://www.nature.com/articles/d41573-024-00131-2
https://www.ispor.org/docs/default-source/intl2024/j-j-access-policy-research---ispor-2024---pharma-r-d-ecosystem-investment137860-pdf.pdf?sfvrsn=d28181d4_0
https://www.tandfonline.com/doi/full/10.1080/13696998.2024.2405407
Resources mentioned in this episode:
https://policyresearch.jnj.com
https://jnjinnovation.com/home
https://www.nature.com/articles/d41573-024-00131-2
https://www.ispor.org/docs/default-source/intl2024/j-j-access-policy-research---ispor-2024---pharma-r-d-ecosystem-investment137860-pdf.pdf?sfvrsn=d28181d4_0
https://www.tandfonline.com/doi/full/10.1080/13696998.2024.2405407
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
